They observed a “key COVID-19 feature” shared by the moderate and severe disease groups, which they defined as the following inflammatory cytokines: IL-1α, IL-1β, IL-17A, IL-12 p70, and IFNα. This evidence concerns the gene IL17A and COVID-19.